Dow Up 0.11% Nasdaq Up 0.50%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
2.98 Up 0.12(4.20%) Aug 29, 4:00PM EDT
Prev Close:2.86
Open:2.97
Bid:2.89 x 200
Ask:N/A
1y Target Est:10.17
Beta:1.18
Next Earnings Date:N/A
Day's Range:2.87 - 2.99
52wk Range:2.21 - 6.84
Volume:416,796
Avg Vol (3m):166,948
Market Cap:47.99M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXIIUp 4.20%47.99M
AGNUp 0.97%48.64B
ALNYUp 1.77%5.32B
MRNADown 5.22%27.94M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):284.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback